What is TMS?

Transcranial Magnetic Stimulation (TMS) is a technological breakthrough in the treatment of Major Depression and it was cleared for use by the FDA in October 2008. TMS is a powerfully effective and safe treatment for Major Depression.

TRMD TMS Patient Sample

It is a non-invasive treatment where MRI strength magnetic pulses are delivered to stimulate nerve cells in the part of the brain controlling the mood, which is often underactive in patients with depression. Response rates to TMS exceed that of medication in treatment resistant patients.

Repeated stimulation of this part of the brain has proven to produce an antidepressant effect on people suffering from depression. TMS is also known as rTMS (repetitive transcranial magnetic stimulation) because more than one magnetic pulse is delivered to the brain during a treatment session. It is given in an office setting without anesthesia, treatments last about 19 minutes and are typically given 5 days a week for four to six weeks. Side effects are minimal and usually only involve some discomfort at the site of treatment during the first week. Patients are able to work, go to school, or continue any of their daily activities

Request More Information about TMS Therapy

How Does TMS Work?

Through a treatment coil, the TMS Therapy system generates highly concentrated, magnetic fields which are rapidly switched on and off. These magnetic fields do not directly affect the whole brain; they only reach a few centimeters into the brain, directly beneath the treatment coil.

TMS (or transcranial magnetic stimulation) refers to a medical treatment which is delivered by a device that generates changing magnetic fields. There are many devices which can be used by clinicians. At present, in general, the devices are positioned over the area of the brain which has been targeted by the clinician. For depression, this area is the prefrontal cortex of the brain. These magnetic fields can create electrical activity in the nerve cells. Biological effects of TMS involves complex mechanisms leading to changes in blood flow and metabolism at stimulation site, alterations of monoamine concentrations and receptors modulation, induction of neurogenesis (BDNF upregulation), enhanced neuroplasticity and increase in grey matter and hippocampal volume. TMS stimulation effects not only the targeted area, the prefrontal cortex, but also the connected areas of the brain, the cingulate, amygdala, hypothalamus, and thalamus.

“It just hurt to be awake, I had no interest in life itself..  That’s when I knew I needed change.”

“After discovering TMS, today I am not a depressed person, I am a happy happy person”

Types of TMS Neuromodulation?

  1. rTMS

    (Types of TMS treatment protocols) The TMS coil delivers the magnetic pulses generated by the stimulator. A single magnetic pulse is delivered while determining the Motor Threshold (magnetic pulse strength needed to cause the twitching of hand finger).rTMS (repetitive transcranial magnetic stimulation): TMS is also known as rTMS (repetitive transcranial magnetic stimulation) because more than one magnetic pulse is delivered to the brain during a treatment session.

  2. Theta Burst TMS

    (EXPRESS TMS): A newer form of rTMS protocol, known as theta‐burst stimulation (TBS), has been shown to produce similar if not greater effects on brain activity than standard rTMS. TBS protocols have a major advantage over standard rTMS approaches in their reduced administration duration. Conventional rTMS procedures last between 20 and 45 min, as compared to TBS paradigms that require 1 to 3 min of stimulation. iTBS stands for intermittent Theta Burst Stimulation and this protocol uses triplet magnetic pulse that enables faster delivery of the treatment. iTBS was cleared by FDA for the same.


    aTMS stands for accelerated transcranial magnetic stimulation. A recent TMS study from 2019 called SAINT ( Stanford Accelerated Intelligent Neuromodulation Therapy) for treatment resistant depression explored the efficacy of an accelerated, high dose iTBS protocol (10 sessions per day with 50 min interval x 5 consecutive days) and reported remission in 86% of participants). It was considered well tolerated and safe, however double blind sham controlled trials are needed to confirm the remission rate observed in this initial study.

    SAINT Protocol: Recent breakthrough called aTMS came from Stanford University and was published in prestigious peer- reviewed American Journal of Psychiatry in April 2020.This SAINT protocol proved the efficacy and safety of accelerated TBS for treatment of treatment resistant depression, the trial included 21 participants with TRD who received 50 sessions of TBS as 10 daily session over 5 consecutive days. Interestingly 19 out of 21 patients ( over 90 percent) met the criteria for remission, with no negative cognitive side effects. Based on 2014 study it was concluded that accelerated TBS treatment in depressed suicidal patients is safe and well tolerated and may have the potential to acutely decrease suicidal ideations.


    The neuronavigation system enables a TMS coil to be positioned over a specified target location based upon an individual’s MRI image, MRI generated 3D curvilinear reconstruction of the brain, or MNI average head model brain.

    In traditional TMS studies the coil is positioned over the head using external landmarks and measurements or by trial and error until the desired response (finger twitch for example) is generated. However in recent years and with the improvement of stereotactic techniques, navigated TMS or Neuronavigation is now possible allowing the TMS coil to be navigated and positioned over a specified target location based upon an individuals MRI image or MRI generated 3D curvilinear reconstruction of the brain.

Accepted Insurance